![]()
|
Report Date : |
13.06.2008 |
IDENTIFICATION
DETAILS
|
Name : |
STAR
LABORATORIES (PVT) LIMITED |
|
|
|
|
Registered Office : |
23-Km, Multan Road (Chung) 53800, Lahore |
|
|
|
|
Country : |
Pakistan |
|
|
|
|
Date of Incorporation : |
1960 |
|
|
|
|
Com. Reg. No.: |
0006071 |
|
|
|
|
Legal Form : |
Private Limited Company |
|
|
|
|
Line of Business : |
Manufacturing of Human, Veterinary and Poultry Medicines |
RATING &
COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
STAR LABORATORIES
(PVT) LIMITED
|
Registered
Address & Factory |
|
23-Km, Multan Road (Chung) 53800,
Lahore-Pakistan. |
|
Tel |
92 (42) 7511331, 7510690, 7512621,7512622 |
|
Fax |
92 (42) 7510163, 7512622 |
|
Website |
|
|
Email |
|
Nature of Business |
Manufacturing Of Human,Veterinary &
Poultry Medicines |
|
Year Established |
1960 |
|
Registration # |
0006071 |
Veterinary Medicines Dept
23-KM, Multan Road Lahore, Lahore,
Pakistan.
Human Medicines Dept
125-A, Canal View,
Thoker Niaz Beig, Lahore, Pakistan.
Rashid Jahangir & Co.
(Chartered
Accountants)
Room # 34, 2nd Floor, Sadiq Plaza, The Mall, Lahore, Pakistan
Subject was established as a Partnership business in 1960 then afterward its legal status was changed to Private Limited Company in 1978
|
Authorized Capital |
Rs. 12,500,000.00 |
|
Issued & Paid up Capital |
Rs. 11,750,000.00 |
|
Names |
Nationality |
Address |
Designation |
|
Mr. Iqbal Hussain Malik Mrs. Salma Malik Mr. M. Israr Hussain Malik Mr. M. Ashar Hussain Malik Mr. Amir Aslam |
Pakistani Pakistani Pakistani Pakistani Pakistani |
50-Sanda Road,
Lahore 50-Sanda Road,
Lahore 50-Sanda Road,
Lahore 50-Sanda Road,
Lahore 50-Sanda Road,
Lahore |
Chief Executive Director Director Director Director |
A. Subsidiary
None
B. Associated Companies
(1) Champion Trading Corporation, Pakistan
Medicine for Human and veterinary
/ Poultry use.
265
(Combined Human & Veterinary Division)
|
SECTION |
RATED CAPACITY ON SINGLE SHIFT BASIS |
UTILIZED CAPACITY |
UN-UTILIZED CAPACITY |
|
INJECTIONS: |
|
|
|
|
Ampoules |
70800000 Nos. |
42480000 Nos. |
28320000 Nos. |
|
Vials |
9600000 Nos. |
5760000 Nos. |
3840000 Nos. |
|
Solutions |
240000 Ltr. |
144000 Ltr. |
96000 Ltr. |
TABLETS:
|
|
|
|
Tablets
|
213600000 Nos. |
128160000 Nos. |
85440000 Nos. |
Boluses
|
7200000 Nos. |
4320000 Nos. |
2880000 Nos. |
OINTMENTS:
|
|
|
|
Ointments
|
1728000 Tubes |
NIL |
1728000 Tubes |
LIQUIDS:
|
|
|
|
Syrup/Drops
|
614400 Ltr. |
368640 Ltr. |
245760 Ltr. |
CAPSULES:
|
|
|
|
Capsules
|
9600000 Nos. |
4500000 Nos. |
5100000 Nos. |
POWDERS:
|
|
|
|
Formulated
|
30000000 Pkt. |
15000000 Pkt. |
15000000 Pkt. |
Repacked
|
2880000 Jars/Bags |
1728000 Jars/Bags |
1152000 Jars/Bags |
|
Year |
In Pak Rupees |
|
2007 |
370,000,000/- (Estimated) |
Mainly to Saudi Arabia, Kuwait, Srilanka, Nigeria, Sudan, U.A.E., Mauritius and Mauritania.
In all major cities of Pakistan
and 10 countries of the world.
|
Year |
US $ |
|
2007 |
1,500,000/- (Estimated) |
Bank Al-Habib Limited.
Bank Al-Falah Limited.
MCB Bank Limited, Pakistan.
Standard Chartered Bank, Pakistan.
Habib Bank Limited, Pakistan.
Faysal Bank Limited, Pakistan.
Many new products has been obtained and being added into production. The
Human Medicines Section is being re-organized with the view to enhance its
productivity and sales. Sales promotion of proprietary drugs is being arranged
so as to mobilize the sales promotion department. On veterinary side, endeavors
are being stepped up to obtain local manufacturing rights of productions of
foreign manufacturers, especially, which are already registered and being sold
in Pakistan. In order to increase sales of human medicines, registration of
Star Laboratories with major government institutions have been applied and
being followed up. For the implementation of above program the induction of new
investors on the basis of equity participation or joint venture is being
solicited.
·
Lahore Chamber of Commerce & Industry.(LCCI)
|
Currency |
Unit |
Pakistani Rupee |
|
US Dollar |
1 |
Rs. 67.70 |
|
UK Pound |
1 |
Rs. 131.45 |
|
Euro |
1 |
Rs. 104.20 |
Star Laboratories (Pvt.) Limited was established in 1960 and is engaged
in manufacture & export of Live Saving Drugs and Medicines for human and
veterinary / poultry use. Company’s market
reputation is good. Trade relations are reported as fair. Subject can be
considered for normal business dealings at usual trade terms and conditions.
RATING
EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit consideration.
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)